Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Avanos

Health Tech & Medtech · Alpharetta, United States · Founded 2002 · IPO 2014 Unicorn

Avanos Medical - Pioneering Healthcare Solutions

Valuation
$1.19B
Market cap · May/2026
Revenue
$701M
Latest reported FY
EBITDA
$58M
Latest reported FY

Global footprint

Where Avanos has talent and traffic

AI talent share
0.1% of workforce is AI talent
(2 of 1,423 staff)
Core AI00%
Other AI20.14%
Non-AI workforce1,42199.86%
Workforce by country
28 countries with
team presence
🇺🇸 United States63.4%
🇲🇽 Mexico19.5%
🇧🇪 Belgium3.6%
🇮🇳 India2.4%
🇬🇧 United Kingdom2%
Top 5 of 28 shown

Patent intelligence

$32M patent portfolio · 44 active families

Estimated portfolio value
$32M
2.7% of market cap · 1.5× the top peer Penumbra ($22M)
44 active patent families
Where Avanos innovates General surgeryMechanical engineeringEnteral feedingsBiomedical engineeringFeeding tube

Where Avanos concentrates vs peers

Each axis is a top-10 topic across Avanos and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Avanos's 3 investments and acquisitions.

Every disclosed deal where Avanos appeared as a backer or acquirer, 2021–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Avanos's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Avanos deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Avanos's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Avanos

        An AI-synthesized read of the highest-engagement posts about Avanos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Avanos on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.